Similarly, it recently has been shown that unsupervised clustering of transcriptional profiles including the top 3000 most variant genes of melanoma patient derived cell lines that developed resistance after long term exposure to BRAF or BRAF/MEK inhibitors, distinguished two different clusters (Song et al. 2017). This evidence concerns the gene MAP2K7 and melanoma.